Patents by Inventor Ventzislav B. Vassilev

Ventzislav B. Vassilev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8889146
    Abstract: The present disclosure provides immunogenic compositions that include at least two paramyxovirus F protein antigens selected from human metapnuemovirus (hMPV), paarainfluenza virus (PIV) and respiratory syncytial virus (RSV). The antigens of the disclosed compositions are recombinant F protein polypeptides, which have been modified to stabilize the trimeric prefusion conformation. Nucleic acids encoding the antigens, as well as methods for their production and use are also provided.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: November 18, 2014
    Assignee: GlaxoSmithKline Biologicals, SA
    Inventors: Ventzislav B. Vassilev, Virginie Van Scherpenzeel Thim, Normand Blais, Patrick Rheault
  • Publication number: 20120135028
    Abstract: The present disclosure provides immunogenic compositions that include at least two paramyxovirus F protein antigens selected from human metapnuemovirus (hMPV), paarainfluenza virus (PIV) and respiratory syncytial virus (RSV). The antigens of the disclosed compositions are recombinant F protein polypeptides, which have been modified to stabilize the trimeric prefusion conformation. Nucleic acids encoding the antigens, as well as methods for their production and use are also provided.
    Type: Application
    Filed: June 24, 2010
    Publication date: May 31, 2012
    Applicants: GlaxoSmithKline Biologicals S.A., Biomedical Corporation of Quebec
    Inventors: Normand Blais, Patrick Rheault, Ventzislav B. Vassilev, Virginie Van Scherpenzeel Thim
  • Patent number: 6001613
    Abstract: A plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus (BVDV), chimeric derivatives of the plasmid and a method of producing an infectious bovine viral diarrhea virus using the plasmid are disclosed. The invention relates to a plasmid DNA molecule that replicates easily in E. coli and contains a sufficient portion of the genome of BVDV, cloned as cDNA, to be a suitable template to produce RNA in vitro which, upon transfection into bovine cells, gives rise to infectious BVDV. The BVDV created by the process of the invention can be engineered for use as a vector in many advantageous applications.
    Type: Grant
    Filed: May 21, 1997
    Date of Patent: December 14, 1999
    Assignee: Board of Regents of University of Nebraska
    Inventors: Ruben O. Donis, Ventzislav B. Vassilev